Abstract: Systems and methods for increasing absorption of ingested substances into a subject's bloodstream are disclosed. The systems and methods involve application of an alternating field to the subject's abdomen, and may further include oral administration of at least one substance to the subject. Also disclosed are methods of treating or reducing the occurrence of a malabsorption condition in a subject via application of the alternating electric field to the subject's abdomen.
Type:
Application
Filed:
June 13, 2023
Publication date:
December 14, 2023
Applicant:
Novocure GmbH
Inventors:
Moshe Giladi, Tali Voloshin-Sela, Lilach Avigdor, Gadi Cohen
Abstract: Organic light-emitting diodes are disclosed comprising an electron transport layer and a hole transport layer. At least one of the transport layers is formed by (a) dissolving tubulin or microtubules in a mixture of water and a solvent that changes the surface charge of tubulin, wherein the percentage of solvent in the mixture is selected so that the tubulin acquires a desired surface charge, and (b) using the tubulin with the desired surface charge to fabricate the at least one of the transport layers. Advantageously, the solvent may be DMSO. Methods of fabricating such organic light emitting diodes are also disclosed.
Type:
Grant
Filed:
June 22, 2021
Date of Patent:
November 14, 2023
Assignee:
Novocure GmbH
Inventors:
Aarat Pratyaksh Kalra, Jack Adam Tuszynski, Sahil Deepak Patel, Karthik Shankar
Abstract: A method to treat a target region of a subject's body with an alternating electric field, the method including: applying the alternating electric field to the target region of the subject's body at a first frequency while increasing an intensity of the alternating electric field from zero to a target intensity; and changing the frequency of the alternating electric field from the first frequency to a target frequency while maintaining the alternating electric field at the target intensity, wherein the target frequency and the target intensity have a known efficacy for treating the target region of the subject's body with the alternating electric field; and wherein the first frequency is greater than the target frequency.
Abstract: Alternating electric fields (e.g., tumor treating fields, a.k.a. TTFields) may be applied to a target region in a subject's body via sheets of graphite that are implanted in the subject's body. One or more ports configured for affixation to the subject's body include or connect to one or more mating electrical connectors. Electrical conductors are positioned to route electrical signals between the electrical connector(s) and the sheets of graphite. The alternating electric fields are applied to the target region by applying (via the ports) an alternating voltage between two sheets of graphite that are positioned on opposite sides of the target region.
Type:
Application
Filed:
March 31, 2023
Publication date:
October 5, 2023
Applicant:
Novocure GmbH
Inventors:
Yoram WASSERMAN, Stas OBUCHOVSKY, Nataliya KUPLENNIK, David SHAPIRO
Abstract: Alternating electric fields (e.g., TTFields) may be induced in a target region in a subject's body by applying, during each of a plurality of first time intervals, a series of pulses of alternating current between electrode elements positioned on or in the subject's body. Immediately following each first interval of time, the electrode elements are allowed to cool. Although the pulses of alternating current within any given first time interval have amplitudes at a level that would cause overheating if the series of pulses was allowed to continue for one hour, each series of pulses does not, in fact, continue for one hour. To the contrary, each series of pulses is short enough to avoid overheating. Interleaving the cooling periods between the pulsing periods enables higher-current pulses to be used, and the use of those higher-current pulses can advantageously improve the efficacy of treatment.
Type:
Application
Filed:
March 30, 2023
Publication date:
October 5, 2023
Applicant:
Novocure GmbH
Inventors:
Tali VOLOSHIN-SELA, Lilach AVIGDOR, Reuven SHAMIR
Abstract: When treating a subject using alternating electric fields (e.g., using TTFields to treat a tumor, or using alternating electric fields to increase the permeability of the blood brain barrier), some subjects experience an unpleasant electrosensation effect. This electrosensation can be reduced or eliminated by increasing the area of the transducer arrays that is active during certain times in the treatment. In some embodiments, this is accomplished by applying an AC signal between two pairs of transducer arrays at certain times (as opposed to the prior art approach of applying an AC signal between two individual transducer arrays).
Abstract: A transducer apparatus for delivering tumor treating fields to a subject’s body, the transducer apparatus including: an array of electrode elements, the array configured to be positioned over the subject’s body with a face of the array facing the subject’s body; wherein, when viewed from a direction perpendicular to the face of the array, an outer perimeter of the array substantially tracing the electrode elements has a shape including: at least one convex edge portion protruding away from a centroid of the array; and at least one concave edge portion recessed toward the centroid of the array.
Abstract: Tumors inside a person's head (e.g., brain tumors) can be treated using tumor treating fields (TTFields) by positioning capacitively coupled electrodes on opposite sides of the tumor, and applying an AC voltage between the electrodes. Unlike the conventional approach (in which all of the electrodes are positioned on the person's scalp) at least one of the electrodes is implemented using an implanted apparatus. The implanted apparatus includes a rigid substrate shaped and dimensioned to replace a section of the person's skull. At least one electrically conductive plate is affixed to the inner side of the rigid substrate, and a dielectric layer is disposed on the inner side of the conductive plate or plates. An electrically conductive lead is used to apply an AC voltage to the conductive plate or plates.
Type:
Application
Filed:
April 13, 2023
Publication date:
August 10, 2023
Applicant:
Novocure GmbH
Inventors:
Yoram WASSERMAN, Uri WEINBERG, Zeev BOMZON
Abstract: Cancer cells can be synchronized to the G2/M phase by delivering an anti-microtubule agent (e.g., paclitaxel or another taxane) to the cancer cells, and applying an alternating electric field with a frequency between 100 and 500 kHz to the cancer cells, wherein at least a portion of the applying step is performed simultaneously with at least a portion of the delivering step. This synchronization can be taken advantage of by treating the cancer cells with radiation therapy after the combined action of the delivering step and the applying step has increased a proportion of cancer cells that are in the G2/M phase. The optimal frequency and field strength will depend on the particular type of cancer cell being treated. For certain cancers, this frequency will be between 125 and 250 kHz (e.g., 200 kHz) and the field strength will be at least 1 V/cm.
Abstract: Alternating electric fields (e.g., TTFields) may be applied to a subject's body using an electrode assembly that includes a skin contact layer formed at least partially of a conductive adhesive. An electrode element is electrically coupled to the conductive adhesive. Optionally, the electrode assembly can include a layer (e.g., sheet) of anisotropic material between the electrode element and the skin contact layer. Optionally, the skin contact layer may comprise an outer adhesive layer comprising conductive adhesive composite, an inner adhesive layer comprising conductive adhesive composite, and a substrate positioned between the inner and outer adhesive layers.
Type:
Application
Filed:
February 28, 2023
Publication date:
August 3, 2023
Applicants:
Novocure GmbH, Novocure GmbH
Inventors:
Rosa S. SHNAIDERMAN, Yoram WASSERMAN, Stas OBUCHOVSKY, Nataliya KUPLENNIK, David SHAPIRO
Abstract: Tumors can be treated with an alternating electric field. The size of cells in the tumor is determined prior to the start of treatment by, for example, biopsy or by inverse electric impedance tomography. A treatment frequency is chosen based on the determined cell size. The cell size can be determined during the course of treatment and the treatment frequency is adjusted to reflect changes in the cell size. A suitable apparatus for this purpose includes a device for measuring the tumor impedance, an AC signal generator with a controllable output frequency, a processor for estimating the size of tumor cells and setting the frequency of the AC signal generator based thereon, and at least one pair of electrodes operatively connected to the AC signal generator such that an alternating electric field is applied to the tumor.
Abstract: Characteristics of alternating electric fields that will be applied to a target region in a subject’s body can be selected by applying different sets of pulses between electrode elements positioned on opposite sides of the target region. Thermal responses to the different sets of pulses are determined. Based on these thermal responses, the system selects a set of characteristics for output pulses of alternating current that will (a) maximize peak current amplitude and (b) keep temperatures at the electrode elements below a threshold value.
Type:
Application
Filed:
December 28, 2022
Publication date:
July 13, 2023
Applicant:
Novocure GmbH
Inventors:
Moshe GILADI, Reuven R. SHAMIR, Kirill STEPOVOY
Abstract: Tumor treating fields (TTFields) can be delivered by implanting a plurality of sets of implantable electrode elements within a person’s body. Temperature sensors positioned to measure the temperature at the electrode elements are also implanted, along with a circuit that collects temperature measurements from the temperature sensors. In some embodiments, an AC voltage generator configured to apply an AC voltage across the plurality of sets of electrode elements is also implanted within the person’s body.
Type:
Application
Filed:
February 14, 2023
Publication date:
June 22, 2023
Applicant:
Novocure GmbH
Inventors:
Yoram WASSERMAN, Zeev BOMZON, Hadas Sara HERSHKOVICH, Ariel NAVEH, Moshe GILADI, Eilon KIRSON, Golan BAR-TAL, Tali VOLOSHIN-SELA
Abstract: This application describes a variety of approaches for generating high voltage sinusoidal signals whose output voltage can be adjusted rapidly, without introducing high-frequency artifacts on the output. When these approaches are used, stronger electric fields can be applied to the tumor for a higher percentage of time, which can increase the efficacy of TTFields therapy. In some embodiments, this is accomplished by preventing adjustments to a DC power source during times when the output of that DC power source is powering the output signal. In some embodiments, this is accomplished by synchronizing the operation of an AC voltage generator and an electronic switch that is connected to the output of the AC voltage generator.
Abstract: A transducer apparatus for delivering tumor treating fields to a subject's body, the transducer apparatus including: an array of electrodes configured to be positioned over the subject's body with a face of the array facing the subject's body; a substrate including an adhesive layer, wherein the array of electrodes is disposed entirely on a first side of the substrate, the face of the array faces away from the substrate, the adhesive layer is on the first side of the substrate facing the same direction as the face of the array; and, when viewed from a direction perpendicular to the face of the array, a non-adhesive region is located between a pair of adjacent electrodes of the array, the non-adhesive region spanning at least 25% of a total distance between the pair of adjacent electrodes for at least one measurement measured along a straight line between the pair of adjacent electrodes.
Abstract: A transducer apparatus for delivering tumor treating fields to a subject's body, the transducer apparatus including: an array of electrodes, the array configured to be positioned over the subject's body with a face of the array facing the subject's body, the array including electrode elements positioned in existing electrode positions arranged around a centroid of the array; and at least one void space in the array capable of enclosing an areal footprint equivalent to at least 40% of an areal footprint of at least one existing electrode position, and superimposable on at least 40% of at least one existing electrode position by rotation of the array around the centroid.
Abstract: A transducer apparatus for delivering tumor treating fields to a subject's body, the transducer apparatus including: a substrate and an array of electrodes disposed on the substrate, the array configured to be positioned over the subject's body with a face of the array facing the subject's body; wherein, when viewed from a direction perpendicular to the face of the array, the substrate has at least one concave edge forming at least a portion of a boundary of the array, the at least one concave edge defines an opening between two opposing sides of the substrate, no electrodes are present in the opening, and the substrate has a substantially C-shaped, U-shaped, rounded V-shaped, or annular shaped surface.
Abstract: A method of determining susceptibility of cancer cells to treatment with alternating electric fields, or of reducing the viability of cancer cells by applying alternating electric fields, by measuring percentage of ciliated cancer cells or by measuring average length of a primary cilia of cancer cells. A method of treating Huntington's disease by applying alternating electric fields to a brain of a subject.
Type:
Application
Filed:
November 29, 2022
Publication date:
June 1, 2023
Applicant:
Novocure GmbH
Inventors:
Matthew R. SARKISIAN, Lilach AVIGDOR, Preshita DESAI
Abstract: Tumors inside a person's head (e.g., brain tumors) can be treated using tumor treating fields (TTFields) by positioning capacitively coupled electrodes on opposite sides of the tumor, and applying an AC voltage between the electrodes. Unlike the conventional approach (in which all of the electrodes are positioned on the person's scalp) at least one of the electrodes is implemented using an implanted apparatus. The implanted apparatus includes a rigid substrate shaped and dimensioned to replace a section of the person's skull. At least one electrically conductive plate is affixed to the inner side of the rigid substrate, and a dielectric layer is disposed on the inner side of the conductive plate or plates. An electrically conductive lead is used to apply an AC voltage to the conductive plate or plates.
Type:
Grant
Filed:
July 24, 2020
Date of Patent:
May 23, 2023
Assignee:
Novocure GmbH
Inventors:
Yoram Wasserman, Uri Weinberg, Zeev Bomzon